Cambrex Customer Recalls Product

Posted on March 24, 2008 @ 08:59 am

Cambrex Corp. announced that one of its customers is recalling a product for which Cambrex currently supplies the active pharmaceutical ingredient (API). The recall decision is not linked to Cambrex's performance as the manufacturer of the API. The recall may impact Cambrex's 2008 performance. Until the customer has resolved the issue, it is unknown what the impact will be. If necessary, the company will update its 2008 guidance when more information becomes available.

Akorn Inks OTC Manufacturing Deal

Posted on March 24, 2008 @ 08:57 am

Akorn, Inc. has signed a five-year commercial manufacturing and supply agreement with a U.S. ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the manufacture and supply of three OTC eye care products. The products will be manufactured at Akorn's Decatur, IL production facility and are targeted for distribution in the U.S. and worldwide markets.
   
Arthur S. Przybyl, Akorn's president and chief executive officer stated, "This partnership reflects Akorn's strong commitment to bringing high quality contract manufacturing services to the ophthalmic industry. We look forward to working closely with our partner to commercialize their OTC line of products."